Pharmaceuticals - Union Register


Register of orphan medicinal products


Product information

Tadekinig alfa

EU orphan designation number: EU/3/16/1763   
Active ingredient: Tadekinig alfa
Indication: Treatment of haemophagocytic lymphohistiocytosis
Sponsor: IQVIA RDS Ireland Limited
Estuary House, East Point Business Park, Fairview, Dublin 3, DO3 Y6A2, Ireland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
18/10/2016 Orphan designation EMA/OD/150/16 (2016)6755 of 14/10/2016
21/03/2018 Transfer of orphan designation EMA/OD/150/16/T/01 (2018)1825 of 19/03/2018
2/05/2018 Change of name and/or address of sponsor